Author Details

Бакулев, Андрей Леонидович

Issue Section Title File
Vol 96, No 2 (2020) DRUG TREATMENT IN DERMATOVENEROLOGY The Actual Challenges of Biologics Treatment in Patients with Psoriasis PDF
(Rus)
Vol 96, No 2 (2020) EDITORIAL Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19 PDF
(Rus)
Vol 97, No 4 (2021) ORIGINAL STUDIES Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial PDF
(Rus)
Vol 97, No 4 (2021) REVIEWS Revisiting the question of cutaneous vasculitis classification PDF
(Rus)
Vol 98, No 2 (2022) ORIGINAL STUDIES Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial PDF
(Rus)
Vol 98, No 4 (2022) REVIEWS Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab PDF
(Rus)
Vol 98, No 6 (2022) REVIEWS Revisiting the question of assessment by severity and classification of acne PDF
(Rus)
Vol 98, No 6 (2022) GUIDELINES FOR PRACTITIONERS About the relationship of rosacea-like dermatitis PDF
(Rus)
Vol 99, No 5 (2023) GUIDELINES FOR PRACTITIONERS Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies